Treatment of immune deficiency with vitamin D compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

552653, A61K 3159, C07C40100

Patent

active

058801146

ABSTRACT:
A method for treating immune deficiency in a mammal by administering an amount of a vitamin D compound, such as Vitamin D.sub.3, its active form 1.alpha.,25-dihydroxyvitamin D.sub.3 or other compounds exhibiting vitamin D-like activity, to the mammal for a sufficient period of time to improve or restore the immunity of the mammal.

REFERENCES:
patent: 4749710 (1988-06-01), Truitt et al.
patent: 5190935 (1993-03-01), Binderup et al.
patent: 5206229 (1993-04-01), Calverley et al.
patent: 5225579 (1993-07-01), Tahara
patent: 5274142 (1993-12-01), Posner et al.
patent: 5447924 (1995-09-01), Bretting
Abe et al, "22-Oxa-1.alpha.,25-dihydroxyvitamin D.sub.3 : A new synthetic analogue of vitamin D having a potent immunoregularting activity without inducing hypercalcemia in mice", Calcium regulation and bone metabolism, pp. 146-151, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of immune deficiency with vitamin D compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of immune deficiency with vitamin D compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immune deficiency with vitamin D compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1321309

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.